首页 | 本学科首页   官方微博 | 高级检索  
     检索      


Response to mason and drakeman's commentary on “fishing for sharks: Partner selection in biopharmaceutical R&D alliances”
Authors:Luis Diestre  Nandini Rajagopalan
Institution:1. IE Business School, Strategy Department, , Madrid, Spain;2. Marshall School of Business, Management and Organization Department, University of Southern California, , Los Angeles, California, U.S.A.
Abstract:We respond to Mason and Drakeman's comment on our published paper titled “Are All ‘Sharks’ Dangerous? New Biotechnology Ventures and Partner Selection in R&D Alliances” (Diestre and Rajagopalan, 2012). We discuss both their survey analysis and alternative explanation and conclude that neither of them invalidates our theoretical premise and our empirical conclusions. Copyright © 2014 John Wiley & Sons, Ltd.
Keywords:R&D alliances  innovation  new ventures  value creation and value appropriation  biopharmaceutical industry
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号